Pure Global

CD14-Expressing Cells Qualitative Testing Reagent - Vietnam Registration 2401138ĐKLH/BYT-HTTB

Access comprehensive regulatory information for CD14-Expressing Cells Qualitative Testing Reagent in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2401138ĐKLH/BYT-HTTB and manufactured by Immunotech SAS. The authorized representative in Vietnam is CÔNG TY TNHH KỸ THUẬT NAM PHƯƠNG.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2401138ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2401138ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

CD14-Expressing Cells Qualitative Testing Reagent
VN: Thuốc thử xét nghiệm định tính các tế bào biểu hiện kháng nguyên CD14
Risk Class TTBYT Loại C

Registration Details

2401138ĐKLH/BYT-HTTB

000.00.04.G18-231024-0015

CD14-ECD

B92391

Company Information

FRANCE

Beckman Coulter, Inc.

Technical Details

The CD14-ECD conjugate antibody enables the qualitative and quantitative determination of CD14-positive cell populations in human biological samples by flow cytometry.

Dates and Status

Jul 22, 2024